Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    December 2016
  1. OGAWA E, Furusyo N, Nomura H, Dohmen K, et al
    NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  2. SETOYAMA H, Tanaka M, Nagumo K, Naoe H, et al
    Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  3. TERAI S, Tsuchiya A
    Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  4. KIYONO S, Maruyama H, Kondo T, Sekimoto T, et al
    Erratum to: Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format    


    July 2016
  5. SAKAIDA I, Terai S, Nakajima K, Shibasaki Y, et al
    Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  6. FUKUI H, Saito H, Ueno Y, Uto H, et al
    Evidence-based clinical practice guidelines for liver cirrhosis 2015.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  7. TANAKA A, Takikawa H, Mochida S, Koike K, et al
    Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".
    J Gastroenterol. 2016.
    PubMed     Text format    


    January 2016
  8. KIYONO S, Maruyama H, Kondo T, Sekimoto T, et al
    Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  9. NAKANISHI H, Kurosaki M, Hosokawa T, Takahashi Y, et al
    Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  10. YANG SL, Liu LP, Sun YF, Yang XR, et al
    Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  11. TADA T, Kumada T, Toyoda H, Kiriyama S, et al
    Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  12. DEGIORGIO D, Crosignani A, Colombo C, Bordo D, et al
    ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  13. NAMISAKI T, Noguchi R, Moriya K, Kitade M, et al
    Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  14. MORISHITA N, Hiramatsu N, Oze T, Harada N, et al
    Erratum to: Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis.
    J Gastroenterol. 2015.
    PubMed     Text format    


    March 2015
  15. FUJIYOSHI M, Kuno A, Gotoh M, Fukai M, et al
    Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    February 2015
  16. SAKAIDA I, Nakajima K, Okita K, Hori M, et al
    Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  17. SASAKI M, Yoshimura-Miyakoshi M, Sato Y, Nakanuma Y, et al
    A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  18. SAKAI Y, Iwata Y, Enomoto H, Saito M, et al
    Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.
    J Gastroenterol. 2015;50:109-18.
    PubMed     Text format     Abstract available


  19. TOSHIMA T, Shirabe K, Ikegami T, Yoshizumi T, et al
    A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
    J Gastroenterol. 2015;50:76-84.
    PubMed     Text format     Abstract available


    December 2014
  20. AOKI Y, Sugiyama M, Murata K, Yoshio S, et al
    Association of serum IFN-lambda with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    November 2014
  21. YASUI K, Kawaguchi T, Shima T, Mitsuyoshi H, et al
    Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    August 2014
  22. HUANG CF, Sun CC, Zhao F, Zhang YD, et al
    miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    June 2014
  23. TATEISHI R, Okanoue T, Fujiwara N, Okita K, et al
    Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


  24. MATSUZAKI K, Seki T, Okazaki K
    TGF-beta signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases.
    J Gastroenterol. 2014;49:971-81.
    PubMed     Text format     Abstract available


    May 2014
  25. IRITANI S, Imai K, Takai K, Hanai T, et al
    Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    December 2013
  26. TAMAKI N, Kurosaki M, Matsuda S, Muraoka M, et al
    Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


  27. YAMASHITA N, Ohho A, Yamasaki A, Kurokawa M, et al
    Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


    October 2013
  28. PATEL T
    New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


  29. SHEEN-CHEN SM , Lin CR, Chen KH, Yang CH, et al
    Epigenetic histone methylation regulates transforming growth factor beta-1 expression following bile duct ligation in rats.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


    September 2013
  30. AIZAWA N , Enomoto H, Takashima T, Sakai Y, et al
    Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


    May 2013
  31. OZE T , Hiramatsu N, Yakushijin T, Miyazaki M, et al
    Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


    March 2013
  32. KUWASHIRO T , Mizuta T, Kawaguchi Y, Iwane S, et al
    Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


  33. KAJI K , Yoshiji H, Ikenaka Y, Noguchi R, et al
    Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: